Squamous Cell Lung Carcinoma Latest Advances

Find the Latest Research About Squamous Cell Lung Carcinoma

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2879 publications

HSR26-216: High LDH-to-Albumin Ratio (LAR) May Represent a Poor Prognostic Marker in Patients With Squamous Cell Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.

HSR26-216: High LDH-to-Albumin Ratio (LAR) May Represent a Poor Prognostic Marker in Patients With Squamous Cell Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Anoikis-Related Genes Signature Contributes to Predicting Prognosis and Response to Immunotherapy in Lung Squamous Cell Carcinoma.

Anoikis-Related Genes Signature Contributes to Predicting Prognosis and Response to Immunotherapy in Lung Squamous Cell Carcinoma.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: March 28, 2026

Pulmonary Squamous Cell Carcinoma Presenting as Glenoid Bone Metastasis: A Case Report.

Pulmonary Squamous Cell Carcinoma Presenting as Glenoid Bone Metastasis: A Case Report.

Journal: Orthopedics

Published: March 26, 2026

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

Journal: JAMA network open

Published: March 18, 2026

Utility of Tissue-of-Origin Algorithms in Cases Diagnosed as Lung Squamous Cell Carcinoma.

Utility of Tissue-of-Origin Algorithms in Cases Diagnosed as Lung Squamous Cell Carcinoma.

Journal: JAMA network open

Published: March 18, 2026

Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis.

Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis.

Journal: Tumori

Published: March 02, 2026

Correction: A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma.

Correction: A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma.

Journal: BMC pulmonary medicine

Published: February 20, 2026

Critical Appraisal of PD-L1 Expression as a Predictive Biomarker for EGFR-TKI Efficacy in Lung Squamous Cell Carcinoma.

Critical Appraisal of PD-L1 Expression as a Predictive Biomarker for EGFR-TKI Efficacy in Lung Squamous Cell Carcinoma.

Journal: American journal of therapeutics

Published: February 11, 2026

Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review.

Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2026

Extrapelvic Urinary Extravasation Caused by Retroperitoneal Metastasis of Pulmonary Squamous Cell Carcinoma: A Case Report.

Extrapelvic Urinary Extravasation Caused by Retroperitoneal Metastasis of Pulmonary Squamous Cell Carcinoma: A Case Report.

Journal: Cureus

Published: February 01, 2026

Deep-Learning-Based Classification of Lung Adenocarcinoma and Squamous Cell Carcinoma Using DNA Methylation Profiles: A Multi-Cohort Validation Study.

Deep-Learning-Based Classification of Lung Adenocarcinoma and Squamous Cell Carcinoma Using DNA Methylation Profiles: A Multi-Cohort Validation Study.

Journal: Cancers

Published: January 16, 2026

TRIM59 (Tripartite Motif-Containing 59) Expression in Pan-Cancer and Its Diagnostic and Prognostic Implications in Breast Cancer, Esophageal Cancer, Lung Squamous Cell Carcinoma, and Stomach Adenocarcinoma.

TRIM59 (Tripartite Motif-Containing 59) Expression in Pan-Cancer and Its Diagnostic and Prognostic Implications in Breast Cancer, Esophageal Cancer, Lung Squamous Cell Carcinoma, and Stomach Adenocarcinoma.

Journal: Cureus

Published: January 14, 2026

Showing 1-12 of 2,879

Last Updated: 04/28/2026